TY  - GEN
AU  - Opal,S M
AU  - Fisher,C J
AU  - Dhainaut,J F
AU  - Vincent,J L
AU  - Brase,R
AU  - Lowry,S F
AU  - Sadoff,J C
AU  - Slotman,G J
AU  - Levy,H
AU  - Balk,R A
AU  - Shelly,M P
AU  - Pribble,J P
AU  - LaBrecque,J F
AU  - Lookabaugh,J
AU  - Donovan,H
AU  - Dubin,H
AU  - Baughman,R
AU  - Norman,J
AU  - DeMaria,E
AU  - Matzel,K
AU  - Abraham,E
AU  - Seneff,M
TI  - Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
SN  - 0090-3493
PY  - 1997///0807
KW  - Adult
KW  - Aged
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Interleukin 1 Receptor Antagonist Protein
KW  - Male
KW  - Middle Aged
KW  - Receptors, Interleukin-1
KW  - antagonists & inhibitors
KW  - Recombinant Proteins
KW  - therapeutic use
KW  - Sepsis
KW  - drug therapy
KW  - Shock, Septic
KW  - Sialoglycoproteins
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00003246-199707000-00010
ER  -